Can urine tests help track kidney disease over time?
Yes—urine test trends and blood-based kidney checks together help track kidney disease, but repeat results matter more than one reading.
A 2026 review in *Innere Medizin* examined evidence about long-term kidney disease. It focused on early warning signs, before people may notice symptoms. This was a review of existing evidence, not one new treatment study.
The review highlighted Urine Albumin / Creatinine Ratio (uACR), a urine test that measures protein leakage. It pairs with eGFR (Estimated GFR), which estimates how well the kidneys filter blood. The two tests tell different parts of the story.
Higher urine ratios were linked to greater risk of death from heart-related causes. Falling ratios were linked to better future kidney health. The summary did not give a percentage drop needed for that benefit. It also did not show that every lower reading means lasting improvement.
For the blood-based estimate, the review cited combined results from treatment studies. Changes averaged over 3 years closely tracked later kidney outcomes. The reported measure of that link was 0.97, where values near 1 mean a very strong link. Predictions were weaker when the early treatment period was left out.
Body fluid levels, infections, and blood pressure can affect results. Early treatment changes can also complicate the picture, especially with heart failure.
For BioSocial members, this supports comparing trends rather than isolated highs or lows. Test dates and notes about illness or treatment changes add useful context. Sharing that context can make community comparisons more meaningful than sharing one number alone.
What have your repeat kidney tests shown, and what was happening around those test dates?

Comments
No comments yet.